Antibody candidate for treating serious liver disease
There is currently no drug for treating non-alcoholic fatty liver disease, which affects many people…
The companies Asimov, BioRay Pharmaceuticals and Colossal Biosciences bagged the biggest biotech investments in January…
Certa Therapeutics has announced what it says are ground-breaking clinical trial data for FT011, its…
cellvie Inc., which works on therapeutic mitochondria transplantation (TMT), an approach developed at Harvard Medical…
There is currently no drug for treating non-alcoholic fatty liver disease, which affects many people…
Evonetix Ltd, a synthetic biology company bringing semiconductor technology to DNA synthesis, has completed a…
Mnemo Therapeutics, a French biotechnology company developing immunotherapies, has announced publication of two scientific studies…
The Access to Advanced Health Institute (AAHI) has been awarded a project agreement worth up…
The US Food and Drug Administration (FDA) has designated the investigation of Endogena Therapeutics’ EA-2353…
Chimeric antigen receptor-T cell (CAR-T) therapy is an exciting treatment modality for blood cancers that…
Our guests are Ofer Sharon, CEO of OncoHost; Matthew Lakelin, co-founder, TrakCel; Pierre Belichard, CEO…
AbbVie has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved…
By Markus Gershater, co-founder and chief scientific officer, Synthace The buzz surrounding generative AI has…